A case series showed that chimeric antigen receptor T-cell therapy targeting CD19 halted the progression of fibrotic organ ...

A research team led by Prof. Wang Haoyi from the Institute of Zoology (IOZ) of the Chinese Academy of Sciences has developed ...

11月27日，中南大学湘雅二医院血液内科彭宏凌教授团队在国际权威期刊Journal of Clinical Investigation（IF=19.4）发表了题为《IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cells》的原创性研究论文 ...

Adoptive cell transfer with chimeric antigen receptor (CAR)-expressing T cells can induce remarkable complete responses in ...

New research has suggested that a simple and 'relatively cheap' supplement or diet could be the key to improving cancer ...

Research shows that GBM organoids are a powerful, accurate tool for understanding what happens when treating a brain tumor ...

The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) is one of several contenders to a heretofore unclaimed crown: engineered cell ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

Cancer immunotherapy strategy equips T cells with molecular GPS that lets them home in on brain tumors and sites of ...

The study reveals IL-15's role in enhancing GPC3 CAR T cell therapy, improving tumor targeting and T cell survival in ...

This study demonstrates the development of PAGERs (programmable antigen-gated engineered receptors), combining antigen ...